INHBE and cancer: Activin is another member of the TGF-β superfamily: elevated levels of plasma activin have been proposed as an adverse prognostic factor in cancer patients [72], and its causative role in mediating catabolic responses and atrophy in muscle cells has been recently demonstrated in vitro [52].